Arnautovic Jelena, Mazhar Areej, Souther Britni, Mikhijan Gary, Boura J, Huda Najia
St. John Macomb, Department of Cardiovascular Medicine, Faculty, Warren MI.
Henry Ford Macomb, Department of Internal Medicine, PGY 3 Resident, Clinton Township, MI.
Spartan Med Res J. 2018 Apr 27;3(1):6516. doi: 10.51894/001c.6516.
The presence of at least one underlying chronic health condition, such as long-term care facility residence, malnutrition, immunosuppression, or prosthetic device use, are well known factors increasing infection risks and progression to severe sepsis. Furthermore, some degree of cardiovascular dysfunction occurs in the majority of septic patients and this prognostic significance has become increasingly recognized. Since septic shock carries the highest mortality risk on the sepsis spectrum, it is important to evaluate the cardiovascular risk impact on mortality in this subset of patients.
The retrospective parent study contributing these electronic health record data was IRB approved and conducted across four hospital intensive care units within the authors' Michigan healthcare system. Patients with cardiopulmonary arrest or transfers from an outside facility were excluded. The authors evaluated the presence of modifiable and non-modifiable cardiovascular risk factors in septic shock patients upon admission to an emergency department.
The authors' final analytic sample included n = 109 adults who were discharged alive compared to those who died during hospitalization. Those patients who died were more often male with an underlying history of hypertension, congestive heart failure, coronary artery disease, or peripheral arterial diseases, were taking pre-admission beta-blocker medications, and had higher APACHE II scores at admission compared to the patients who survived to discharge. Significantly higher mortality risks were found in sample patients with increased troponin levels on admission and atrial fibrillation.
Appropriate triage and prompt treatment of these patient groups with tailored therapy to stabilize and improve cardiac dysfunction in the emergency department could potentially lead to improved survival outcomes. Clinicians need more studies to determine therapeutic targets most impacting underlying pathophysiologic mechanisms such as elevated troponin and atrial fibrillation that greatly increase mortality risks.
存在至少一种潜在的慢性健康状况,如长期居住在护理机构、营养不良、免疫抑制或使用假体装置,是增加感染风险和发展为严重脓毒症的众所周知的因素。此外,大多数脓毒症患者会出现一定程度的心血管功能障碍,这种预后意义已得到越来越多的认可。由于感染性休克在脓毒症谱系中具有最高的死亡风险,因此评估心血管风险对这一患者亚组死亡率的影响非常重要。
提供这些电子健康记录数据的回顾性母体研究经机构审查委员会批准,在作者所在的密歇根医疗系统的四个医院重症监护病房进行。排除心肺骤停患者或从外部机构转诊的患者。作者评估了脓毒性休克患者在急诊科入院时可改变和不可改变的心血管危险因素的存在情况。
作者的最终分析样本包括109名存活出院的成年人,与住院期间死亡的成年人进行比较。与存活出院的患者相比,那些死亡的患者更常为男性,有高血压、充血性心力衰竭、冠状动脉疾病或外周动脉疾病的病史,入院前服用β受体阻滞剂药物,且入院时急性生理与慢性健康状况评分系统(APACHE II)得分更高。入院时肌钙蛋白水平升高和心房颤动的样本患者的死亡风险显著更高。
对这些患者群体进行适当的分诊,并在急诊科采用量身定制的治疗方法进行及时治疗,以稳定和改善心脏功能障碍,可能会改善生存结果。临床医生需要更多的研究来确定对潜在病理生理机制影响最大的治疗靶点,如大幅增加死亡风险的肌钙蛋白升高和心房颤动。